Histopathological classification of non-functioning pituitary neuroendocrine tumors

被引:0
作者
Emilija Manojlovic-Gacic
Britt Edén Engström
Olivera Casar-Borota
机构
[1] University of Belgrade,Institute of Pathology, School of Medicine
[2] Uppsala University Hospital,Department of Medical Sciences, Endocrinology and Metabolism
[3] Uppsala University,Department of Immunology, Genetics and Pathology
[4] Uppsala University Hospital,Department of Clinical Pathology
来源
Pituitary | 2018年 / 21卷
关键词
Non-functioning pituitary neuroendocrine tumor; Pituitary adenoma; Immunohistochemistry; Transcription factors;
D O I
暂无
中图分类号
学科分类号
摘要
Non-functioning pituitary neuroendocrine tumors do not cause endocrine symptoms related to hypersecretion of adenohypophyseal hormones and are clinically characterized by symptoms due to growing sellar tumor mass. Histopathological classification of this tumor group has always been challenging due to their heterogeneity, limited knowledge on their biology, and diverse methodological problems. We have searched PubMed database for data related to the histopathological classification of non-functioning pituitary tumors and methods for its application. Principles of the classification and grading presented in the recently released 4th edition of the World Health Organization classification of endocrine tumors have been summarized. Based on the expression of anterior pituitary hormones and pituitary specific transcription factors, gonadotroph tumors dominate within the group of clinically non-functioning tumors, followed by corticotroph type; however, other less common types of the non-functioning tumors can be identified. Assessment of tumor cell proliferation is important to identify “high-risk adenomas.” A few subtypes of non-functioning tumors belong to the category of potentially aggressive tumors, independent of the cell proliferation rate. Here, we present up to date criteria for the classification of clinically non-functioning pituitary tumors, offer a diagnostic approach for the routine clinical use, and emphasize a need for inclusion of prognostic and predictive markers in the classification.
引用
收藏
页码:119 / 129
页数:10
相关论文
共 757 条
[1]  
Asa SL(2017)From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal Endocr Relat Cancer 24 C5-c8-436
[2]  
Casar-Borota O(2014)Silent (clinically nonfunctioning) pituitary adenomas J Neurooncol 117 429-460
[3]  
Chanson P(2012)Subclinical hyperfunctioning pituitary adenomas: the silent tumors Best Pract Res Clin Endocrinol Metab 26 447-382
[4]  
Delgrange E(2010)Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK) Clin Endocrinol 72 377-4275
[5]  
Earls P(2010)Incidence of pituitary adenomas in Northern Finland in 1992–2007 J Clin Endocrinol Metab 95 4268-526
[6]  
Ezzat S(2014)The incidence rate of pituitary adenomas in western Sweden for the period 2001–2011 Eur J Endocrinol 171 519-200
[7]  
Grossman A(2010)Factors predicting relapse of nonfunctioning pituitary macroadenomas after neurosurgery: a study of 142 patients Eur J Endocrinol 163 193-446
[8]  
Ikeda H(2017)Radiological predictors for extent of resection in pituitary adenoma surgery. A single-center study World Neurosurg 108 436-744
[9]  
Inoshita N(2011)Can we ever stop imaging in surgically treated and radiotherapy-naive patients with non-functioning pituitary adenoma? Eur J Endocrinol 165 739-1897
[10]  
Karavitaki N(2017)Outcome of nonfunctioning pituitary adenomas that regrow after primary treatment: a study from two large UK centers J Clin Endocrinol Metab 102 1889-34